EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features

Abstract The aim of this study was to evaluate the expression of the EZH2 protein and describe the clinical and microscopic characteristics of adenoid cystic carcinoma (ACC) and pleomorphic adenoma (PA). The study included 16 ACC cases and 12 PA. All ACC and PA cases were positive for EZH2 and the A...

Full description

Bibliographic Details
Main Authors: Mariana Saturnino de NORONHA, Karolina Skarlet Silva VIANA, Maria Cássia Ferreira de AGUIAR, Cristiane Helena SQUARIZE, Mauro Henrique Nogueira Guimarães de ABREU, Elismauro Francisco MENDONÇA, Vanessa de Fátima BERNARDES
Format: Article
Language:English
Published: Sociedade Brasileira de Pesquisa Odontológica 2024-03-01
Series:Brazilian Oral Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242024000109500&lng=en&tlng=en
_version_ 1797265346359459840
author Mariana Saturnino de NORONHA
Karolina Skarlet Silva VIANA
Maria Cássia Ferreira de AGUIAR
Cristiane Helena SQUARIZE
Mauro Henrique Nogueira Guimarães de ABREU
Elismauro Francisco MENDONÇA
Vanessa de Fátima BERNARDES
author_facet Mariana Saturnino de NORONHA
Karolina Skarlet Silva VIANA
Maria Cássia Ferreira de AGUIAR
Cristiane Helena SQUARIZE
Mauro Henrique Nogueira Guimarães de ABREU
Elismauro Francisco MENDONÇA
Vanessa de Fátima BERNARDES
author_sort Mariana Saturnino de NORONHA
collection DOAJ
description Abstract The aim of this study was to evaluate the expression of the EZH2 protein and describe the clinical and microscopic characteristics of adenoid cystic carcinoma (ACC) and pleomorphic adenoma (PA). The study included 16 ACC cases and 12 PA. All ACC and PA cases were positive for EZH2 and the ACC samples showed significantly higher EZH2 expression. The clinical and microscopic covariates were described in relation to EZH2 staining in ACC samples. The highest mean values of EZH2 were observed in cases with local metastasis, recurrence, perineural invasion, and predominantly cribriform growth pattern without solid areas. EZH2 is a potential marker of malignancy.
first_indexed 2024-04-25T00:43:20Z
format Article
id doaj.art-af1b98e6c7fc48cba0dbdc550b285605
institution Directory Open Access Journal
issn 1807-3107
language English
last_indexed 2024-04-25T00:43:20Z
publishDate 2024-03-01
publisher Sociedade Brasileira de Pesquisa Odontológica
record_format Article
series Brazilian Oral Research
spelling doaj.art-af1b98e6c7fc48cba0dbdc550b2856052024-03-12T07:42:51ZengSociedade Brasileira de Pesquisa OdontológicaBrazilian Oral Research1807-31072024-03-013810.1590/1807-3107bor-2024.vol38.0018EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological featuresMariana Saturnino de NORONHAhttps://orcid.org/0000-0001-9188-1939Karolina Skarlet Silva VIANAhttps://orcid.org/0000-0001-6467-1434Maria Cássia Ferreira de AGUIARhttps://orcid.org/0000-0001-5134-3466Cristiane Helena SQUARIZEhttps://orcid.org/0000-0002-6782-3429Mauro Henrique Nogueira Guimarães de ABREUhttps://orcid.org/0000-0001-8794-5725Elismauro Francisco MENDONÇAhttps://orcid.org/0000-0002-6751-3279Vanessa de Fátima BERNARDEShttps://orcid.org/0000-0003-0194-7434Abstract The aim of this study was to evaluate the expression of the EZH2 protein and describe the clinical and microscopic characteristics of adenoid cystic carcinoma (ACC) and pleomorphic adenoma (PA). The study included 16 ACC cases and 12 PA. All ACC and PA cases were positive for EZH2 and the ACC samples showed significantly higher EZH2 expression. The clinical and microscopic covariates were described in relation to EZH2 staining in ACC samples. The highest mean values of EZH2 were observed in cases with local metastasis, recurrence, perineural invasion, and predominantly cribriform growth pattern without solid areas. EZH2 is a potential marker of malignancy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242024000109500&lng=en&tlng=enImmunohistochemistryEnhancer of Zeste Homolog 2 ProteinSalivary Gland NeoplasmsCarcinoma, Adenoid CysticAdenoma, Pleomorphic
spellingShingle Mariana Saturnino de NORONHA
Karolina Skarlet Silva VIANA
Maria Cássia Ferreira de AGUIAR
Cristiane Helena SQUARIZE
Mauro Henrique Nogueira Guimarães de ABREU
Elismauro Francisco MENDONÇA
Vanessa de Fátima BERNARDES
EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
Brazilian Oral Research
Immunohistochemistry
Enhancer of Zeste Homolog 2 Protein
Salivary Gland Neoplasms
Carcinoma, Adenoid Cystic
Adenoma, Pleomorphic
title EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
title_full EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
title_fullStr EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
title_full_unstemmed EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
title_short EZH2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
title_sort ezh2 immunoexpression in pleomorphic adenoma and adenoid cystic carcinoma and clinicopathological features
topic Immunohistochemistry
Enhancer of Zeste Homolog 2 Protein
Salivary Gland Neoplasms
Carcinoma, Adenoid Cystic
Adenoma, Pleomorphic
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242024000109500&lng=en&tlng=en
work_keys_str_mv AT marianasaturninodenoronha ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT karolinaskarletsilvaviana ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT mariacassiaferreiradeaguiar ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT cristianehelenasquarize ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT maurohenriquenogueiraguimaraesdeabreu ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT elismaurofranciscomendonca ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures
AT vanessadefatimabernardes ezh2immunoexpressioninpleomorphicadenomaandadenoidcysticcarcinomaandclinicopathologicalfeatures